Skip to main content

Volume 3 Supplement 1

ESICM LIVES 2015

Effects of L-lysine aescinat on intracranial pressure in patients with severe traumatic brain injury

Introduction

Increased intracranial pressure (ICP) results in cerebral blood flow decrease and cerebral edema formation. Correction of intracranial hypertension (ICH) is one of the most important goals of intensive care in patients with severe traumatic brain injury (TBI).

Objectives

To determine the effects of L-lysine aescinat on ICP in patients with severe TBI.

Methods

Twenty patients with TBI and Glasgow coma scale below 9 enrolled in the study. Mean age was 39.3 ± 13.6 years, male/female - 18/2. All patients were operated: 6 patients underwent craniotomy and intracranial hematoma removing; 11 - decompressive craniotomy and intracranial hematoma removing. In 3 patients only ICP-sensor was implanted. ICP-monitoring was used in all patients. Ten patients were randomized to L-lysine aescinat treatment (daily dose of 20 ml for 7 days after surgery) (study group), 10 - to standard therapy (control group). We perfomed a comparative analysis of the mean ICP and the incidence of ICH within 7 days after surgery in the study and control groups.

Results

The length of ICP monitoring was 6.4 ± 3.7 days: in the control group - 7.6 ± 4.9 days, in the study group - 5.2 ± 1.4 days. Mean intracranial pressure (mmHg) was less in the study group as compared to patients in the control group: 1st day - 14.3 ± 5.9 (n = 136) vs 17.0 ± 3.8 (n = 156), 2nd day - 15.7 ± 5.4 (n = 158) vs 17.4 ± 4.6 (n = 141), 3rd day - 17.0 ± 6.5 (n = 144) vs 17.1 ± 6.9 (n = 161), 4th day - 17.3 ± 9.5 (n = 163) vs 20.7 ± 5.9 (n = 135), 5th day - 14.6 ± 5.9 (n = 83) vs 18.9 ± 5.6 (n = 136), 6th day - 12.8 ± 4.5 (n = 79) vs 15.9 ± 6.4 (n = 66), 7th day - 12.4 ± 8.6 (n = 56) vs 14.4 ± 7.6 (n = 95). The number of intracranial hypertension episodes was higher in the control group compared with patients who received L-lysine aescinat: 1st day - 4.2 ± 4.2 vs 2.8 ± 3.3, 2nd day - 6.5 ± 5.1 vs 3.0 ± 2.5, 3rd day - 6.0 ± 8.0 vs 2.6 ± 3.3, 4th day - 9.6 ± 10.1 vs 3.4 ± 3.8, 5th day - 7.4 ± 8.2 vs 2.6 ± 3.7, 6th day - 7.3 ± 8.6 vs 0.4 ± 0.9, 7th day - 5.0 ± 9.3 vs 1.3 ± 1.3.

Conclusions

L-lysine aescinat treatment in patients with severe traumatic brain injury is accompanied by reduction of mean intracranial pressure and the number of intracranial hypertension episodes.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Krylov, V., Petrikov, S., Solodov, A. et al. Effects of L-lysine aescinat on intracranial pressure in patients with severe traumatic brain injury. ICMx 3 (Suppl 1), A853 (2015). https://doi.org/10.1186/2197-425X-3-S1-A853

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2197-425X-3-S1-A853

Keywords

  • Hypertension
  • Blood Flow
  • Comparative Analysis
  • Traumatic Brain Injury
  • Cerebral Blood Flow